Published in
Elsevier, European Journal of Cancer, (152), p. 26-40, 2021
DOI: 10.1016/j.ejca.2021.04.015
Links
Tools
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”
Journal article published in 2021 by
Patrick Schöffski 
,
Maud Toulmonde,
Anna Estival ,
Gloria Marquina ,
Monika Dudzisz-Śledź,
Mehdi Brahmi,
Neeltje Steeghs,
Vasilios Karavasilis ,
Jacco de Haan ,
Agnieszka Wozniak ,
Sophie Cousin,
Marta Domènech,
Judith V. M. G. Bovée,
Céline Charon-Barra,
Sandrine Marreaud
and other authors.
,
Maud Toulmonde,
Anna Estival ,
Gloria Marquina ,
Monika Dudzisz-Śledź,
Mehdi Brahmi,
Neeltje Steeghs,
Vasilios Karavasilis ,
Jacco de Haan ,
Agnieszka Wozniak ,
Sophie Cousin,
Marta Domènech,
Judith V. M. G. Bovée,
Céline Charon-Barra,
Sandrine Marreaud
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 